You are here

Heart Failure


Individuals with higher levels of cardiac troponin in their blood are at greater risk for developing heart failure for the first time, according to a meta-analysis published in JACC: Heart Failure.

The prevalence of left ventricular systolic dysfunction (LVSD) has declined over the last 30 years, and heart failure patients are increasingly demonstrating preserved ejection fraction versus reduced ejection fraction, according to a study published in JACC: Cardiovascular Imaging.

Previously sedentary, middle-aged adults who devote themselves to regular aerobic exercise for two years can increase their maximal oxygen uptake and decrease cardiac stiffness, according to new research published in Circulation.

Women who undergo hysterectomies—especially those under 35 years old—are nearly five times more likely to develop congestive heart failure and are at increased risk for a slew of other coronary complications, according to a study of more than 2,000 Minnesota women.

More than 10 percent of heart transplant recipients developed cancer between one and five years post-transplantation—most commonly skin cancer—according to a study published in the Journal of the American College of Cardiology.


Recent Headlines

Advanced heart failure patients have superior outcomes with HeartMate 3 device

At six months, patients with advanced heart failure who were implanted with the HeartMate 3 left ventricular assist system were less likely to have hemocompatibility- related clinical adverse events (HRAEs) compared with those who received the HeartMate II device, according to a randomized trial.

Taller, overweight women could be at increased risk for AFib

New research from the University of Gothenburg in Sweden has suggested that bigger women, classified as those who are taller than average and are overweight, could be at a greater risk of atrial fibrillation (AFib).

Protein shown to improve cardiac function could be used for heart failure drugs

Researchers from Case Western Reserve University have found a new target for drug developers looking for ways to improve cardiac function in heart failure patients.

Subclinical hypothyroidism associated with adverse cardiac outcomes

New research from the University of Pennsylvania shows that patients with severe heart failure have higher levels of thyroid hormones, which can be responsible for causing atrial fibrillation.

Gene mutation could help develop drug to reduce heart attacks

A person's unique genetic makeup may mean greater chances of certain harmful conditions, but other times, one's genes can actually be a defense against negative health outcomes. New research from Washington University’s School of Medicine in St. Louis explores how this concept could help develop therapies intended to reduce the risk of heart attack.

Insomnia linked to increased risk of heart failure, stroke

New research from China has found insomnia can be a cause for an increased risk in having a heart attack or stroke, a finding that can help cardiologists better predict a patient’s risk for experiencing an adverse cardiac event.

Heart failure medication falls short of primary endpoint in phase 3 trial

Novartis announced that a phase 3 study evaluating the company’s investigational heart failure medication (serelaxin) did not meet its primary endpoint.

ACC.17: Medicare beneficiaries implanted with CardioMEMS system have lower rate of heart failure hospitalizations

Medicare beneficiaries who received an implantable pulmonary artery pressure (PAP) sensor had a statistically significant 45 percent lower rate of heart failure hospitalizations and reduced costs at six months, according to a retrospective cohort study.

ACC.17: Detroit cardiologists increase cardiogenic shock survival rate to 84% using Abiomed heart pump

A coalition of medical centers in southeast Michigan have found a way to increase the survival rate of cardiogenic shock patients to 84 percent by using a heart pump manufactured by Danvers, Massachusetts-based Abiomed. 

ACC.17: Research at ACC shows that marijuana increases risk for heart failure, stroke

Though cannabis has increasingly been making its way into healthcare as a method for treating a series of conditions, new research on the drug, presented at the American College of Cardiology (ACC)’s Scientific Session beginning March 17, finds that it could cause severe cardiovascular events.